Picture of Tabula Rasa HealthCare logo

TRHC — Tabula Rasa HealthCare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Tabula Rasa HealthCare Inc expected to post a loss of 2 cents a share - Earnings Preview

* Tabula Rasa HealthCare Inc  TRHC.OQ   TRHC.O  is expected
to show a rise in quarterly revenue when it reports  results 
    * The Moorestown New Jersey-based  company is expected to
report 
a 18.2% increase in revenue to $91.171 million from $77.1
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Tabula Rasa
HealthCare
Inc is for a loss of 2 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $10.5​, above​ its last closing price
of $10.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.10       -0.12      0.03      Beat    125.5
 Mar. 31 2023  -0.14       -0.14      -0.02     Beat    85.7
 Dec. 31 2022  -0.22       -0.06      -0.05     Beat    23.1​
 Sep. 30 2022  -0.19       -0.11      -0.26     Missed  -132.1
 ​​Jun.        -0.17       -0.12      -0.25     Missed  -111.9
 30 2022                                                
 Mar. 31 2022  -0.16       -0.16      -0.22     Missed  -40​
 Dec. 31 2021  -0.09       -0.08      -0.09     Missed  -14.3
 Sep. 30 2021  0.02        0.03       -0.04     Missed  -218.5
 This summary was machine generated October 30 at 13:02 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Tabula Rasa HealthCare

See all news